Do you have the same question? Follow this Question
Jan 22, 2026 - 01:03 PM
We’ve provided several answers to questions related to Bimzelx (Bimekizumab) , see some other helpful Q&A related to this product.
Question: How does Bimzelx work in the body?
Answer: Bimzelx (bimekizumab) is a monoclonal antibody that works by selectively blocking two inflammatory proteins, interleukin-17A (IL-17A) and interleukin-17F (IL-17F). By inhibiting these proteins, Bimzelx reduces inflammation and helps improve symptoms in conditions like plaque psoriasis.
Question: What is the KEGG identifier for this medication?
Answer: The KEGG ID is D11567. KEGG stands for Kyoto Encyclopedia of Genes and Genomes, a database that helps researchers understand drugs and their biological pathways.
Question: How is the total dose typically administered?
Answer: The total dose is usually 320 mg, split into two injections of 160 mg each. Splitting the dose can make administration easier and may help reduce injection site reactions.
